title: Successful management of Mycobacterium haemophilum lower extremity cutaneous infection in a matched-unrelated donor stem cell transplant recipient.
abstract: Nontuberculous mycobacterial infections can often occur in individuals with adequate immune function. Such infections typically have cutaneous involvement and are caused by rapidly growing mycobacterium. Other nontuberculous mycobacteria species, like Mycobacterium haemophilum, almost always present as opportunistic infections occurring in severely immunocompromised hosts. Here, we present a complicated and protracted course of diagnosing M. haemophilum lower extremity cutaneous infection in a matched-unrelated donor stem cell transplant recipient.
authors: Division of Infectious Diseases, Department of Internal Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
authors: Aliyah
authors: A
authors: Baluch
authors: Division of Infectious Diseases, Department of Pharmacy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
authors: Yanina
authors: Y
authors: Pasikhova
authors: Department of Pharmacy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
authors: Matthew
authors: http://orcid.org/0000-0002-4763-7223
authors: M
authors: Snyder
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001706:Biopsy; D002481:Cellulitis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D002939:Ciprofloxacin / Q000627:therapeutic use; D017291:Clarithromycin / Q000627:therapeutic use; D005260:Female; D006086:Graft vs Host Disease / Q000175:diagnosis / Q000188:drug therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D015470:Leukemia, Myeloid, Acute / Q000601:surgery*; D035002:Lower Extremity; D008875:Middle Aged; D009165:Mycobacterium Infections, Nontuberculous / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D018393:Mycobacterium haemophilum / Q000302:isolation & purification*; D009894:Opportunistic Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D017828:Rifabutin / Q000627:therapeutic use; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use; D061349:Unrelated Donors
chemical_list: D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D017828:Rifabutin; D002939:Ciprofloxacin; D017291:Clarithromycin; D016559:Tacrolimus
keywords: 
  Mycobacterium haemophilum
  ; nontuberculous mycobacteria; nontuberculous mycobacterial infection; opportunistic infection; stem cell transplantation